The Street Is Finally Waking Up To Zentalis Pharmaceuticals Inc (NASDAQ: ZNTL)

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.

Stocks Info

Zentalis Pharmaceuticals Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of Zentalis Pharmaceuticals Inc is $105.56M. A total of 1.61 million shares were traded on the day, compared to an average of 1.53M shares.

In the most recent transaction, Bruns Ingmar bought 20,000 shares of ZNTL for 2.28 per share on Feb 06 ’25. After the transaction, the Chief Medical Officer now owns 36,629 company shares. In a previous transaction on Feb 11 ’25, Cam Gallagher bought 687 shares at 2.00 per share.

Among the insiders who sold shares, Vultaggio Vincent disposed of 2,615 shares on Feb 03 ’25 at a per-share price of $1.71. This resulted in the PAO and Interim PFO holding 189,826 shares of ZNTL after the transaction. In another insider transaction, Lackner Mark sold 14,368 shares at $1.71 per share on Feb 03 ’25. Company shares held by the Chief Scientific Officer now total 512,856.

Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, ZNTL has a high of $13.46 and a low of $1.01.

Balance Sheet Annually/Quarterly

A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. ZNTL’s latest balance sheet shows that the firm has $339.89M in Cash & Short Term Investments as of fiscal 2021. There were $44.46M in debt and $43.94M in liabilities at the time. Its Book Value Per Share was $4.73, while its Total Shareholder’s Equity was $364.48M.

Analysts Opinion

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ZNTL is Buy with a score of 3.80.

Most Popular

Related Posts